Wednesday, 15th November Clinical Oncology Society of Australia Annual Scientific Meeting 2017

Chair: Kahlil Lawless
Speaker: 
David Thomas, Garvan 

Monika Krzyzanowska
Becoming a pro with PRO.

• How long will this go on? Decisions about treatment duration and stopping. - Catriona McNeil
• Uncertainty in immunotherapy raises the question: what is the GP role in primary cancer treatment? - Geoffrey Mitchell
• Speaker TBC (Caregiver) - Jane Turner
• When am I a survivor: changing perspectives on metastatic cancer and its impact on cancer nursing - Mei Krishnasamy
• Living in uncertain spaces: psychological impact of rapidly evolving treatment options - Haryana Dhillon

• Colorectal cancer genetics and precision medicine in the new era  - Aung Win
• Utility of panel testing in familial cancer - Kathy Tucker
• Immunotherapy in dMMR and Lynch syndrome Gastrointestinal tumours - Margaret Lee
• Translating cancer genetics evidence into practice: impact on patients and practitioners - Natalie Taylor

• The role of optimal care pathways in achieving system reform - Kathryn Whitfield
• Development of a clinically embedded patient-reported outcome framework - lessons learnt - Mei Krishnasamy
• Primary health care reform – implications for cancer care - Jon D Emery
• Innovations in community pharmacy: implications for cancer care - Anne M Develin

• Immunotherapy vol.2: Desperately looking for hot tumors - Tobias Bald
• Some like it hot! - Jonathan Cebon
• Targeting RANK Ligand Pathways in Combination Immunotherapy - Elizabeth Ahern

• Digital Guidelines - an International Perspective - Jutta Thwaites
• Maintaining the Standard of Guidelines - Davina Ghersi
• Challenges of writing new guidelines - Phyllis Butow
• Chemotherapy Guidelines and Controversy. The safe delivery of cancer therapy.   - Christine Carrington
• Using Education to Disseminate and implement Guidelines   - Ian N Olver

Speaker: Richard De Crespigny

Moderator: Adam Spencer
Panel:

David Currow
Jen Morris
Anne O’Neill
Gabrielle Prest
Karen van Gorp